Janon, Sendoy .
HRN: 22-39-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2024
AMPICILLIN 1GM (VIAL)
05/11/2024
05/18/2024
IV
350mg
Q6hours
PCAP-B
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes